FX.co ★ Enovis Names Davide Visentin As New Head Of International Surgical Unit

Enovis, a prominent global medical technology firm, announced on Friday the appointment of Davide Visentin as the new President of Enovis International Surgical, effective March 1. Visentin will take over from Benjamin Reinmann, who has been instrumental in developing the company's International Surgical Business. Prior to this role, Visentin held the position of Vice President and General Manager of the Integrated Diagnostic Solutions Business Unit at BD. Currently, Enovis shares are trading at $46.70 on the Nasdaq, reflecting an increase of 2.71%, or $1.23.